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Abstract
Background: Synaptic loss strongly correlates with memory deterioration. Local accumulation of amyloid β (Aβ)
peptide, and neurotoxic Aβ42 in particular, due to abnormal neuronal activity may underlie synaptic dysfunction,
neurodegeneration, and memory impairments. To gain an insight into molecular events underlying neuronal activity-
regulated Aβ production at the synapse, we explored functional outcomes of the newly discovered calcium-dependent
interaction between Alzheimer’s disease-associated presenilin 1 (PS1)/γ-secretase and synaptic vesicle proteins.
Results: Mass spectrometry screen of mouse brain lysates identified synaptotagmin 1 (Syt1) as a novel synapse-specific
PS1-binding partner that shows Ca2+-dependent PS1 binding profiles in vitro and in vivo. We found that Aβ level, and
more critically, conformation of the PS1 and the Aβ42/40 ratio, are affected by Syt1 overexpression or knockdown,
indicating that Syt1 and its interaction with PS1 might regulate Aβ production at the synapse. Moreover, β-secretase 1
(BACE1) stability, β- and γ-secretase activity, as well as intracellular compartmentalization of PS1 and BACE1, but not of
amyloid precursor protein (APP), nicastrin (Nct), presenilin enhancer 2 (Pen-2), or synaptophysin (Syp) were altered in
the absence of Syt1, suggesting a selective effect of Syt1 on PS1 and BACE1 trafficking.
Conclusions: Our findings identify Syt1 as a novel Ca2+-sensitive PS1 modulator that could regulate synaptic Aβ, opening
avenues for novel and selective synapse targeting therapeutic strategies.
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Background
Presenilin 1 (PS1) constitutes the catalytic site of the γ-
secretase complex [1, 2] involved, together with β-
secretase 1 (BACE1) [3], in amyloid precursor protein
(APP) processing and amyloid β (Aβ) production. Ab-
normal Aβ production is implicated in the pathogenesis
of Alzheimer’s disease (AD) — a neurodegenerative dis-
order characterized by progressive memory deterioration
(reviewed in [4, 5]). Although the exact sequence of
events occurring in the brain and causing AD is not well
understood, it appears that Aβ accumulation occurs
before the onset of cognitive decline [5, 6] and that
synaptic loss most closely correlates with the memory
impairments [7–9]. Moreover, traceable Aβ deposition
could already be detected in the default mode network
brain regions in cognitively normal adults [10], and ex-
perimentally induced synaptic activity was shown to in-
crease Aβ production [11–13], indicating a link between
synaptic activity and Aβ. Interestingly, the level of Aβ in
the brain interstitial fluid is closely linked to synaptic
vesicle (SV) exocytosis [14]. These findings suggest that
Aβ can be produced locally at the synapse in an
activity-dependent manner. However, molecular events
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and proteins involved in neuronal activity-modulated
levels of synaptic Aβ remain largely unknown.
Synaptotagmin 1 (Syt1) is a key molecule regulating syn-
aptic vesicle (SV) exocytosis in a calcium [Ca2+]-dependent
manner [15, 16]. Syt1 contains two Ca2+-binding domains,
C2A and C2B, and is one of the major calcium sensors at
the synapse promoting SV exocytosis and neurotransmitter
release in response to Ca2+ influx [16–18]. Interestingly,
increased intracellular calcium levels also enhance produc-
tion of Aβ and Aβ42 in particular [19–21], implying that
Ca2+ influx may modulate the cleavage of APP by β- and
γ-secretases. Still, little is known about the local synaptic
effects of neuronal activity and Ca2+ on APP processing.
In the present study, we focused on, and searched for,
potential neuronal activity-dependent modulators that
can affect γ-secretase activity. We found that PS1 adopts a
pathogenic “closed” conformation within minutes of Ca2+
influx triggered by glutamate or KCl treatment, suggesting
a Ca2+-dependent mechanism. An unbiased proteomics
screen of the mouse brain lysates in the presence or
absence of Ca2+ identified Syt1 as a novel Ca2+-dependent
PS1- interacting protein, showing robust Syt1-PS1 binding
in the presence of high Ca2+. Furthermore, we found that
Syt1 may regulate Aβ production via different mecha-
nisms. We report that Syt1 modulates the architecture
and activity of the PS1/γ-secretase complex affecting the
Aβ species produced, is important for BACE1 matur-
ation and stability, and is involved in trafficking and
compartmentalization of BACE1 and PS1. Taken to-
gether, these data suggest that Syt1 acts as a novel
pre-synaptic calcium-dependent interactor of the PS1/
γ-secretase that can regulate APP processing and, thus,
Aβ production/secretion at the synapse in an activity-
dependent manner.
Results
PS1 conformation is dynamically regulated by Ca2+ influx
in intact neurons
Neuronal activation is reported to modulate Aβ produc-
tion and elevate the Aβ42/40 ratio [13, 19, 21]. The
latter correlates with distinct conformation of the PS1/γ-
secretase [22–25]. To probe for possible dynamic changes
in PS1/γ-secretase in live cells in response to neuronal
stimulation we used our previously developed ratiometric
spectral Förster Resonance Energy Transfer (FRET) assay
that utilizes GFP-PS1-RFP (G-PS1-R) as a reporter of PS1
conformation (Fig. 1a). As determined previously, the G-
PS1-R protein can traffic through the secretory pathway
to the plasma membrane, shows similar subcellular distri-
bution to that of endogenous PS1, can be incorporated
into the γ-secretase complex, is efficiently endoproteo-
lyzed, and reconstitutes the γ-secretase enzymatic activity
in PS1/2 double knockout mouse embryonic fibroblasts
(MEF) [25]. The change in the proximity between RFP
and GFP fluorophore-tagged PS1 loop- and NT-domains
(FRET efficiency) corresponds to the change in the ratio of
RFP (598 nm) to GFP (513 nm) fluorescence intensity (R/
G ratio). The higher the R/G ratio the closer the two do-
mains are, indicating so-called “closed” PS1 conformation.
Primary neurons (12–14 days in vitro [DIV]) were
transfected with the G-PS1-R and imaged every
~30 seconds prior to and after KCl bath treatment in-
ducing membrane depolarization. We detected a rapid
increase in the R/G ratio within the first minute of the
stimulation, which lasted for at least 30 minutes (Fig. 1b
and Additional file 1). This suggests that PS1 has a
dynamic structure that responds rapidly to KCl treat-
ment by changing the NT-loop proximity. To confirm
this finding, we used another stimulus, glutamate (Glu)
that was applied transiently by puffing it directly onto
the imaged neuron. Again, a rapid increase in the R/G
ratio was observed, indicating a change in the PS1 con-
formation. In this case, however, the R/G ratio returned
to the baseline within 2 minutes, indicating that PS1
conformation was able to recover when the stimulant
diffused (Fig. 1b). No change in the R/G ratio was ob-
served in H2O-treated neurons or in neurons treated
with Glu in the Ca2+/Mg2+ free media. Additional file 1
shows the GFP and RFP emission intensities and the R/
G ratio in cells expressing GFP-PS1 (negative FRET
control), GFP-RFP fusion (positive FRET control) or
GFP-PS1-RFP, during 30 minutes recording. No GFP or
RFP photobleaching was observed under the settings
used. The increased R/G ratio after KCl application
reflects increased FRET efficiency and is observed in G-
PS1-R expressing cells only.
To verify that both treatments increase intracellular
calcium load ([Ca2+]I), sister cultures were preloaded
with Oregon Green 488 BAPTA-1 AM and imaged using
time-lapse settings. Changes in the [Ca2+]I strongly cor-
related with the R/G ratio (Fig. 1c).
These data reveal the dynamic nature of the PS1/γ-secre-
tase and suggest that continuous insult (high intracellular
Ca2+) maintains PS1/γ-secretase in a “closed” conformation,
while a transient stressor modulates PS1 reversibly.
Furthermore, after 15 minutes of KCl treatment we
could already detect increased levels of the secreted
Aβ40 (150.5 ± 21.63 %, p = 0.0294) and Aβ42 (168.1 ±
27.24 %, p = 0.0286), resulting in an increased Aβ42/40
ratio (Fig. 1d) and consistent with the PS1 adopting a
“closed” conformation at high intracellular Ca2+.
Synaptotagmin 1 is a novel calcium-dependent
PS1-binding partner
To search for potential Ca2+-dependent modulators of
the PS1/γ-secretase at the synapse, we performed an un-
biased mass spectrometry (MS) proteomics screen of
wild type (wt) mouse brain lysed in 1 % Triton X-100 in
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Fig. 1 PS1 conformation and Aβ production change upon KCl or glutamate treatment. a Schematic representation of the “open” (left) and “closed” (right)
PS1 conformation; green and red circles represent green fluorescent protein (GFP) and red fluorescence protein (RFP) fused to PS1 NT and L6-7, respectively,
to generate FRET reporter probe. b Time-lapse recording of PS1 conformational changes in live neurons transfected with GFP-PS1-RFP FRET reporter probe
and treated with KCl, glutamate, or water control. The Spectral FRET data are presented as a change in the RFP/GFP ratio, 50 to 100 neurons were analyzed
for each condition; the graph shows mean ± SEM; detailed statistical analysis of the Spectral FRET data evaluation is described in the Methods. c Time-lapse
recording of Oregon Green 488 BAPTA-1 AM fluorescence intensity changes reflecting intracellular calcium load in primary neurons treated with KCl,
glutamate, or water control. Three independent experiments, mean ± SEM. d ELISA measurements of secreted Aβ40 and Aβ42 in conditioned-
medium collected from KCl (KCl+) or H2O (KCl-) treated mouse cortical neurons. The Aβ levels determined in pmol were normalized to the
amount of total protein [g] extracted from the cells in the corresponding well. Data are presented as mean% ± SEM, n = 4; 100 % = 91.11 pmol/g for
Aβ40 and 11.04 pmol/g for Aβ42. Statistical significance was determined using the Mann-Whitney U test, *p < 0.05. PS1 presenilin 1, Aβ amyloid β, NT
N-terminus, FRET Förster Resonance Energy Transfer
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the presence or absence of Ca2+. Using GST-tagged pep-
tides corresponding to PS1 domains or GST alone as a
control, synaptotagmin 1 (Syt1) was identified as a strong
candidate for novel PS1-interacting presynaptic protein
(Table 1, Fig. 2, and Additional file 2). Syt1 interaction with
PS1 was the strongest when GST-fused PS1 L6-7 peptide
was used as “bait”, although a smaller number of Syt1 pep-
tides was also pulled down with the GST-PS1 NT peptide.
Since both L6-7 and PS1 NT sequences used for the pull
down are localized within the post-endoproteolytic PS1
N-terminal fragment, the data suggest that Syt1 inter-
acts with the PS1 NTF. Importantly, Ca2+ level affected
the interaction between PS1 and Syt1, with robust PS1-
Syt1 binding observed in the presence of high Ca2+.
Identification of known Ca2+-insensitive PS1 interac-
tors, such as catenin delta1, reaffirmed the specificity of
the assay for Ca2+-dependent PS1 binding partners.
PS1 co-localizes with Syt1 at presynaptic terminals
To establish if PS1 co-localizes with Syt1 in the pre-
synaptic terminals, we triple-immunostained synapto-
neurosomes (SNSs) isolated from wt mouse cerebral
cortex for: 1) PS1, 2) Syt1, and 3) either synapsin 1
(Syn1) and vesicular glutamate transporter 1 (vGlut1)
or microtubule-associated protein 2 (MAP2), as pre-
and postsynaptic markers, respectively.
Bright field imaging and immunostaining demonstrate
the presence of the snowman-shaped SNSs formed by
pre- and post-synaptic terminals (inserts in Fig. 3a)
and co-localization of endogenous PS1 with Syt1,
Syn1, and vGlut1 at the presynapse, in addition to PS1
presence at the postsynapse (Fig. 3a). Of note, a
fraction of the synaptic terminals was PS1 negative in
both pre- and post-synaptic compartments. Enrich-
ment of the PS1/γ-secretase in the SNSs was further
confirmed by western blotting and PS1-colloidal gold
immunoelectron microscopy of mouse brain tissue
(Fig. 3b and c). The latter showed that PS1 is present
in synaptic vesicles of both the reserve and release-
ready pools at the presynaptic membrane and within
the postsynaptic terminals.
PS1 interacts with Syt1 on endogenous levels
The use of recombinant GST-PS1 peptide pull-down
in the mass spectrometry screen has some limita-
tions due to the possibility of improper folding.
Therefore, to verify occurrence of the interaction on
endogenous level, we employed a different approach:
co-immunoprecipitation (co-IP) of PS1/γ-secretase
with Syt1 using 1 % CHAPSO-solubilized extracts of
mouse hippocampi, primary neurons, and cerebral
cortex synaptoneurosomes (SNSs). Indeed, Syt1 was
co-immunoprecipitated with PS1 (Fig. 4), suggesting
a physiological function of the interactions between
PS1 and Syt1 in the brain. Of note, other members
of the γ-secretase complex were also pulled down with Syt1
from the 1 % CHAPSO-solubilized extracts, in which inter-
actions among components of the γ-secretase complex are
retained (Fig. 4a).
To validate the Ca2+-dependence of the interactions,
SNS fractions were subjected to IP in the presence of
2 mM CaCl2 (Ca
2++) or 2 mM EGTA (Ca2+-). Indeed,
more Syt1 was co-immunoprecipitated with PS1 in the
high Ca2+ condition (Fig. 4c). There was no significant
effect of Ca2+ on the immunoreactivity of total lysates
(input lanes in Fig. 4c) or the efficiency of PS1 NTF and
CTF interaction.
To examine which fragment of PS1 (NTF or CTF)
predominantly binds Syt1, SNS fractions were lysed in
1 % Tx-100 buffer, disrupting interactions between the
γ-secretase components [26]. The Syt1 band was de-
tected only when anti-PS1 NT antibody was used for
the pull-down, suggesting that Ca2+-bound Syt1 select-
ively interacts with the PS1 N-terminal fragment
(Fig. 4d). Since the largest amount of the Syt1 peptides
during the MS screen was pulled down with the PS1
peptide corresponding to the amino acids (aa) 263–376
of the L6–7 domain, the region was further narrowed
to the aa 263–293, the C-terminal part of the PS1 NTF.
Of note, a smaller number of the Syt1 peptides was also
detected in the GST-PS1 NT (aa 1–80) pull-down;
hence, it is possible that this region provides an
additional, lower-affinity interface for the interaction
(Fig. 4d).
Table 1 Mass spectrometry screen identified Syt1 as a novel synaptic PS1-binding protein that shows calcium-dependent profile of
the interaction
PS1 bait Binding protein Accession number Gene symbol Unique/total peptides Sequence coverage Protein function
Ca2+(+) Ca2+(-) Ca2+(+) Ca2+(-) Ca2+(+)
NT Synaptotagmin 1 NP033332 SYT1 4/4 None 11.6 % None Calcium sensor for synaptic vesicle
fusion and neurotransmitter release
L6-7 Synaptotagmin 1 NP033332 SYT1 16/26 2/2 32.1 % 5.0 %
L6-7 Catenin delta 1 NP031641 CTNND1 17/20 25/35 20.9 % 30.8 % Known presenilin 1 interactor in
the brain
The number of peptides identified and the sequence coverage for Syt1 in Ca2+ (-) and Ca2+ (+) conditions is shown. A known PS1 interacting protein, Catenin1
delta, is shown as Ca2+-independent control
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Next, we tested whether Ca2+ influx into mouse primary
neurons due to KCl-induced membrane depolarization or
calcium ionophore treatment would enhance endogenous
interaction between PS1 and Syt1. For this, 21–28 days in
vitro cultured neurons were treated with KCl or Ca2+ iono-
phore (A23187) and subjected to co-IP/western blotting.
An increased level of Syt1 co-immunoprecipitated with
PS1 in the KCl-stimulated neurons (134.34 ± 3.14 %, p =
0.0004), compared to those treated with vehicle (Fig. 5a).
An even higher increase was detected when a stronger
stimulant, Ca2+ ionophore, was used (208.6 ± 22.78 %, p =
0.0089). Collectively, these data provide strong evidence
for endogenous, activity- and Ca2+ influx-regulated PS1-
Syt1 interactions in neurons.
Fig. 2 Mass spectrometry analysis of the PS1 interacting proteins. a Coomassie-stained gel of the proteins eluted from the column. The gel slices
with bands of different sizes were excised from the Ca2+ (+) and Ca2+ (-) condition from the GST-PS1 pull-downs, and were sent for mass
spectrometry analysis (indicated by lines to the right of the gel). The slice selection was based on the differences in the protein profiles/band
intensities between GST-control and GST-PS1 pull-down, GST-PS1 pull-down from brain lysates vs. lysis buffer, and between Ca2+ (+) and Ca2+ (-) condition
(these bands are indicated with the asterisks). The bands containing Syt1 are indicated with arrowheads. Three independent MS screens were performed.
The Table shows number of peptides identified and the sequence coverage for Syt1 in Ca2+ (-) and Ca2+ (+) conditions; catenin1 delta is shown as Ca2+-
independent control. b Image of the coomassie stained gel from a different MS experiment shows differences in the band intensities for proteins pulled
down with the GST-PS1 L6-7 (the area is overexposed in Fig. 2a). The arrowhead points to the band containing Syt1. c Schematic representation of the PS1
molecule and the GST-fusion peptides used in the MS screen of the Triton X-100-digested mouse brain lysates for PS1-binding partners; gray cylinders
correspond to PS1 transmembrane domains. PS1 fragments used in the pull-down are labeled in red, green and blue. PS1 presenilin 1, GST glutathione
S-transferase, Syt1 synaptotagmin 1, MS mass spectrometry
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Syt1-PS1 interaction in intact neurons is stimulated by
KCl treatment
To further validate and characterize endogenous PS1-Syt1
interactions in intact neurons, we employed an antibody-
based fluorescence lifetime imaging microscopy (FLIM)
analysis. The FRET efficiency (%EFRET), reflecting relative
proximity between the fluorophore-labeled PS1 L6-7 epi-
tope and Syt1, was increased in neurons stimulated with
KCl, compared to vehicle-treated, suggesting more PS1-
Syt1 interactions in the former (Fig. 5b).
Fig. 3 PS1/γ-secretase present in the pre- and post-synaptic terminals. a Confocal microscopy imaging shows co-localization of PS1 with Syt1 (left)
and with synapsin1 and vGlut1 (right) in presynaptic compartments of isolated synaptoneurosomes (SNSs, arrowheads). Arrows show MAP2-positive
post-synaptic buttons. Insert on the left shows a bright field image of isolated SNS. b Western blot analysis of PS1 CTF, Nct, Pen-2, Syt1 and β actin as a
control in total homogenate (H) and synaptoneurosome (S) fractions from wild type mouse brain. Enrichment of the γ-secretase components in SNS
vs. total brain homogenate is quantified. Data are presented as mean ± SEM, n = 4. Statistical significance was determined using the unpaired student
t-test; * p < 0.05, *** p < 0.001. c Electron micrographs of synaptic terminals from mouse cortex immunostained for PS1 (gold particles). Red circles and
arrows indicate positive staining in presynaptic and postsynaptic compartments, respectively. PS1 presenilin 1, Syt1 synaptotagmin 1, vGlut1 vesicular
glutamate transporter 1, MAP2 microtubule-associated protein 2, CTF C-terminal fragment, Nct nicastrin, Pen-2 presenilin enhancer 2
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To determine subcellular localization of the PS1 and
Syt1 interactions, donor lifetime was color-coded and
mapped on a pixel-by-pixel basis through the entire
image. Shortest lifetimes (yellow-to-red pixels) were re-
corded mainly along the processes and co-localized with
the dotted pattern of Syt1 immunoreactivity, presenting
synaptic boutons as sites of the KCl-induced PS1-Syt1
interaction (Fig. 5b). Of note, KCl treatment resulted in
a significant increase in the %EFRET along the processes,
without having a considerable effect on PS1-Syt1 interac-
tions in the cell bodies. These findings reaffirm that PS1
and Syt1 interaction occurs on endogenous level, and that
Fig. 4 PS1 interacts with Syt1 on endogenous level. a Syt1 co-immunoprecipitates with PS1 from mouse hippocampi. The co-IP assay was
conducted using anti-PS1 CT and anti-PS1 NT antibodies for pull-down; the detection antibodies are indicated to the left of each blot, n = 3.
b PS1 co-immunoprecipitates with Syt1 from mouse cortical primary neurons. The co-IP assay was conducted using anti-Syt1 antibody for
pull-down; the detection antibodies are indicated to the left of the blot. Other γ-secretase components pulled-down with Syt1 in the 1 %
CHAPSO buffer are shown, n = 4. c Syt1 co-immunoprecipitates with PS1 from synaptoneurosome (SNS) fractions in a Ca2+-dependent manner.
SNS were solubilized in 1 % CHAPSO buffer in the presence or absence of 2 mM CaCl2. N-terminal PS1 antibody (or IgG control) were used for
pull-co-immunoprecipitated with PS1 NTF (normalized to the respective PS1 NTF band intensities). All the data are presented as mean ± SEM,
n = 4. Statistical significance was determined using the unpaired student t-test, * p < 0.05. d Syt1 co-immunoprecipitates with PS1 from mouse
SNSs solubilized in 1 % TritonX-100 buffer in the presence of 2 mM CaCl2 when anti-PS1 NT, but not anti-PS1 loop or anti-PS1 CT antibody, is
used for pull-down. The detection antibodies are indicated on the left side of the blot. Schematic representation of the PS1 molecule; the
presumed Syt1 interaction sites are shown. PS1 presenilin 1, Syt1 synaptotagmin 1, IP immunoprecipitation, CT C-terminus, NT N-terminus, NTF
N-terminal fragment
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Ca2+-influx induces the interaction primarily at the Syt1-
positive loci along the dendrites in primary neurons.
Syt1 3D-A mutations impair Ca2+-dependent interactions
between PS1 and Syt1
To gain further insight into the Ca2+-dependency of the
Syt1 interaction with PS1, we constructed a 3D-A Syt1
mutant by substituting for alanine three aspartate resi-
dues important for Ca2+ binding [27]. PC12 cells lacking
Syt1 (Syt1 KD) were transfected with wild type or 3D-A
Syt1-V5 plasmids, treated with KCl or vehicle, harvested,
and subjected to co-IP/western blotting. As expected,
significantly enhanced interaction of wt Syt1-V5 with
PS1 was observed in response to KCl. In contrast, 3D-A
Fig. 5 PS1 interacts with Syt1 in Ca2+-dependent manner in primary neurons. a Co-immunoprecipitation experiments demonstrate that KCl (n= 3)
or calcium ionophore A23187 treatment (n= 3) of primary neurons that trigger Ca2+ influx strengthen the interaction between PS1 and Syt1. The asterisk
shows a non-specific, heavy chain IgG band. The graph presents quantitative analysis of the Syt1 band intensity, mean ± SEM. Statistical significance was
determined using the unpaired student t-test, ** p< 0.01, *** p< 0.001. b FLIM analysis of the PS1-Syt1 proximity in mouse cortical primary neurons
treated for 5 minutes with 50 mM KCl (KCl+) or water control (KCl-). Fluorescence images show PS1 (green) and Syt1 (red) immunoreactivity. Scale bar:
5 μm. Pseudo-colored FLIM images depict lifetime of the Alexa 488 donor fluorophore. Colorimetric scale shows fluorescence lifetime in picoseconds.
Zoomed boxed area shows FLIM image superimposed onto a table indicating average lifetimes for each pixel (~0.2 um2) of the image. Shortest lifetimes
(yellow-to-red) reflect closest proximity between PS1 and Syt1. Bar graph presents [%] FRET efficiency (PS1-Syt1 proximity) recorded in the outlined
regions of interest (ROIs) corresponding to the neuronal cell bodies or the processes. (mean ± SEM; n= 82 for cell bodies KCl(-), n= 63 for cell bodies
KCl(+), n= 128 for processes KCl(-) and n= 146 for processes KCl(+); unpaired student t-test, *** p < 0.001). PS1 presenilin 1, Syt1 synaptotagmin 1, FLIM
fluorescence lifetime imaging microscopy, FRET Förster Resonance Energy Transfer
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Syt1-V5 binding to PS1 was significantly reduced com-
pared to that of wt Syt1 in KCl-treated cells (Fig. 6a, c).
Analogously, the interaction between mutant 3D-A
Syt1-V5 and PS1 in Ca2+ ionophore-treated Chinese
hamster ovary (CHO) cells was significantly weaker
compared to that of wt Syt1-V5 and PS1 (Fig. 6b, c).
These results support the importance of Ca2+ binding to
Syt1 in the regulation of the PS1-Syt1 interactions.
Syt1 affects endogenous Aβ production and PS1
conformation
The above data provide strong evidence that Ca2+ in-
flux promotes Syt1-PS1 interactions and dynamically
modulates PS1 conformation in neurons. Therefore,
we reasoned that Syt1 might be involved in regulation
of the Aβ production/secretion and/or PS1 conform-
ation. To gain insight into how Syt1 may modulate Aβ
levels, we employed Syt1 knockdown and overexpres-
sion approaches using parental and Syt1 KD PC12 cells
(Additional file 3). Aβ40 and Aβ42 levels were reduced
by 37.69 ± 2.15 % and 25.63 ± 4.31 % (p < 0.0001), re-
spectively, in Syt1 KD cells (Fig. 7a). The deficits were
partially rescued by transient Syt1-V5 expression in
Syt1 KD cells. Conversely, transient overexpression of
Syt1-V5 in parental PC12 cells led to increased levels
of both Aβ40 and Aβ42, by 16.30 ± 5.46 % and 22.16 ±
8.66 % (p < 0.05), respectively. Of note, the levels of
intracellular Aβ40 and Aβ42 were not significantly dif-
ferent between the parental and Syt1 KD PC12 cells
(Fig. 7b), suggesting that Aβ generation may be impaired.
To test whether KCl/Ca2+ influx-induced changes in
PS1 conformation and Aβ production/secretion ob-
served in neurons (Fig. 1b, d) are mediated by Syt1, we
monitored PS1 NT-loop proximity and Aβ40 and Aβ42
levels in parental and Syt1 KD PC12 cells. The cells
were transfected with G-PS1-R FRET reporter and
treated with KCl in regular or Ca2+/Mg2+ free media.
Similarly to neurons, a significant increase in the
%EFRET was observed in parental PC12 cells in the
regular, Ca2+/Mg2+-containing (but not in the Ca2
+/Mg2+-free) media, indicating that KCl-triggered
pathological “closed” PS1 conformation requires the
presence of Ca2+ ions (Fig. 7c). This corresponded to
the KCl-induced increase in the Aβ40 and Aβ42 levels
and the Aβ42/40 ratio in parental PC12 cells (Fig. 7d).
On the contrary, no changes in PS1 conformation and
Fig. 6 Mutations in Syt1 at Ca2+–binding aspartate residues disrupt Ca2+-dependent Syt1-PS1 interaction. a Western blot analysis of the Syt1
co-immunoprecipitated with PS1 from 1 % CHAPSO lysed Syt1 KD PC12 cells transiently transfected with Syt1.wt or Syt1.3D-A encoding vectors, following
15-minute 50 mM KCl (KCl+) or water control (KCl-) treatment. Inp.- input cell lysate shows a comparable level of Syt1 in cells transfected with wild type
and 3D-A mutant Syt1. IgG (control) or PS1 CT antibody was used for pull-down. b PS70 CHO cells were transfected with Syt1.wt or Syt1.3D-A expression
plasmids, treated for 15 minutes with 5 μM Ca2+ ionophore (A23187), and lysed in 1 % CHAPSO buffer. PS1-Syt1 complexes were immunoprecipitated
using anti-PS1 NT, anti-PS1 CT or anti-PS1 loop antibodies. The immunoprecipitation efficiency was determined by re-probing the membrane with PS1
antibodies used for pull-down. c Quantitative analysis of the Syt1 co-immunoprecipitated with PS1 from PC12 (n= 3) and CHO (n= 6) in high calcium
condition after KCl and calcium ionophore treatment, respectively. More Syt1.wt than Syt1.3D-A was co-immunoprecipitated with PS1 in the above
conditions. All the data are presented as mean ± SEM. Statistical significance was determined using the unpaired student t-test, *** p < 0.001.
Syt1 synaptotagmin 1, PS1 presenilin 1, wt wild type, CT C-terminus, NT N-terminus, CHO Chinese hamster ovary
Kuzuya et al. BMC Biology  (2016) 14:25 Page 9 of 24
Fig. 7 (See legend on next page.)
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Aβ in response to Ca2+ influx were detected in Syt1KD
cells. Interestingly, whereas %EFRET (Fig. 7c) and the
Aβ42/40 ratio (Fig. 7d) were not affected by calcium in
Syt1 KD, their baseline values were significantly higher
in the absence of Syt1. These data suggest that, al-
though the total level of Aβ is reduced by Syt1 KD, the
presence of Syt1 is required for the maintenance of the
Aβ42/40 ratio and PS1 in the physiological, “normal”
conformation.
Since Aβ levels were significantly reduced in Syt1 KD
cells, we tested whether interactions between APP sub-
strate and PS1/γ-secretase may be affected. We detected
decreased proximity between the PS1 loop domain and
APP CT in Syt1 KD cells, suggesting reduced PS1-APP
interaction in the absence of Syt1 (Fig. 7e). In addition,
while KCl treatment of parental PC12 cells increased
%EFRET (PS1-APP proximity), it had no effect on the
%EFRET in Syt1 KD cells. Taken together, these data sug-
gest that Syt1 may modulate Aβ levels by influencing the
assembly and/or activity of PS1/γ-secretase and its inter-
action with the APP substrate.
Syt1 modulates γ-secretase activity
A co-IP/western-blot analysis of the PS1 CTF co-
immunoprecipitation with PS1 NTF and with the other
γ-secretase components in parental and Syt1 KD PC12
cells showed increased binding between PS1 CTF and
NTF, as well as between PS1 and Pen-2 and Aph1a in
the absence of Syt1 (Fig. 8a). This indicates that Syt1
deficiency affects γ-secretase architecture and promotes
tighter association of its components. The finding is
consistent with the more compact “closed” PS1 conform-
ation in Syt1 KD cells, as detected by the FLIM assay. At
the same time, decreased levels of the PS1 N-terminal and
C-terminal fragments along with the diminished Pen-2
were detected in Syt1 KD cells (Fig. 8b), suggesting reduc-
tion of the functional γ-secretase in the absence of Syt1.
To test more directly if Syt1 may affect PS1/γ-secre-
tase activity, we performed a cell-free in vitro γ-secretase
activity assay using recombinant C100-FLAG substrate
(APP β-CTF) and membrane preparations from parental
and Syt1 KD PC12 cells containing active γ-secretase. A
~30 % reduction of the Aβ40 production was detected
in Syt1 KD cells (Fig. 8c). A similar trend was recorded
for Aβ42 but the data did not reach statistical significance.
These data confirm partial loss of γ-secretase catalytic
activity in the absence of Syt1. Of note, the APP intracel-
lular domain (AICD) level remained unaltered (Fig. 8c),
supporting the hypothesis that γ-secretase cleavage of the
APP β-CTF occurs in a step-wise manner [28, 29], and
loss of γ-secretase activity results in “incomplete diges-
tion” of the APP CTF substrate in Syt1 KD cells. Likewise,
the γ-secretase-dependent cleavage of Notch1 at the
membrane-cytoplasm interface leading to generation of
the Notch1 intracellular domain (NICD) was not affected
in the absence of Syt1 in PC12 Syt1 KD cells (Fig. 9).
Syt1 modulates APP processing
The role of Syt1 in APP processing was further investi-
gated by analyzing the levels of endogenous APP C-
terminal fragments and secreted APPβ (sAPPβ) in the
presence and absence of Syt1 in PC12 cells. About a
22.57 ± 5.21 % (p < 0.001) decrease in the total APP CTF/
FL ratio was observed in Syt1 KD cells, suggesting that α-
and/or β-secretase cleavage of APP may be affected
(Fig. 10a). Indeed, the sAPPβ/APP FL ratio was decreased
by about 32.25 ± 9.15 % (p < 0.001) in the absence of Syt1
(Fig. 10a). On the other hand, in CHO cells lacking en-
dogenous Syt1 but stably overexpressing human APP and
Syt1-V5 or only APP, the APP CTF/APP FL, sAPPα/APP
FL, and sAPPβ/APP FL ratios were significantly increased
in cells overexpressing Syt1 (Fig. 10b).
BACE1 maturation and degradation are affected in Syt1
KD cells
The reduced amount of sAPPβ suggests that in addition
to the γ-secretase activity, BACE1 activity may also be
affected in Syt1 KD cells. Indeed, the level of endogen-
ous total BACE1 was significantly decreased, whereas
the level of immature BACE1 detected by prodomain-
(See figure on previous page.)
Fig. 7 Aβ production/secretion and PS1 conformation are altered by Syt1 KD. a, b ELISA measurements of the endogenous (A) secreted and (B)
intracellular Aβ40 and Aβ42 in parental and Syt1 KD PC12 cells stimulated for 15 minutes with 50 mM KCl. The secreted Aβ levels determined in
pmol were normalized to the total protein extracted from the cells in the same well. (A) n= 5 for parental + Syt1-V5 and n= 6 for all other conditions; (B)
n= 4. 100 % equals to 212.93 pmol/g and 20.06 pmol/g for secreted Aβ40 and Aβ42, respectively. 100 % for intracellular Aβ40 and Aβ42 equals to 1.92
pmol/g and 0.575 pmol/g, respectively. c FLIM analysis of the FRET efficiency [%] reflecting PS1 conformational changes in parental and Syt1 KD PC12
cells; n= 101 cells for parental Ca2+(-), n= 103 for parental Ca2+(+), n= 84 for Syt1 KD Ca2+(-) and n= 86 for Syt1 KD Ca2+(+). Higher values correspond to
“closed” conformational state of PS1. The cells were placed in Ca2+/Mg2+-free (-) or Ca2+/Mg2+-containing (+) medium, prior to treatment with 50 mM
KCl. d ELISA measurements of the endogenous Aβ40, Aβ42 and Aβ42/Aβ40 ratio in the conditioned medium from parental and Syt1 KD cells (n= 8).
e FLIM analysis of endogenous APP and PS1 proximity (FRET efficiency [%]) in parental and Syt1 KD PC12 cells; n= 83 cells for parental Ca2+(-), n= 89 for
parental Ca2+(+), n= 70 for Syt1 KD Ca2+(-) and n= 64 for Syt1 KD Ca2+(+). The cells were treated for 5 minutes with 50 mM KCl in Ca2+/Mg2+-free or
normal medium, fixed, and immunostained for PS1 and APP. The data in all panels of the Figure are presented as mean ± SEM. The statistical significance
was determined using the unpaired student t-test. *p< 0.05; ** p < 0.01; ***p < 0.001. Aβ amyloid β, PS1 presenilin 1, Syt1 synaptotagmin 1, FLIM
fluorescence lifetime imaging microscopy, FRET Förster Resonance Energy Transfer, APP amyloid precursor protein
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specific antibody was increased in Syt1 KD cells, relative
to that in parental PC12 cells. Thus, the total/immature
BACE1 ratio was reduced by 58.19 ± 5.14 % (p < 0.0001)
in the absence of Syt1 (Fig. 11a).
The low levels of mature BACE1 were at least partially
due to a drastic reduction in the BACE1 protein half-life
in Syt1 KD cells, as revealed by the cycloheximide pulse
chase assay (Fig. 11b). Of note, no difference in the
Fig. 8 Syt1 influences the architecture of γ-secretase complex and Aβ generation but not AICD production. a Western blot analysis of the γ-secretase
complex members co-immunoprecipitated from parental and Syt1 KD PC12 cells lysed in 1 % CHAPSO (n = 4). The bottom gel shows the level of Syt1
in the input lysates and after pull-down with PS1 C-terminal antibody or IgG control. The graph presents quantitative analysis of the PS1 NTF, Pen-2
and Aph1a co-IPed with the PS1 C-terminal fragments. The intensities of the bands were measured by densitometry, and adjusted to the intensity of
the input bands and to the PS1 CTF (IP efficiency control). b Quantitative analysis of the PS1 FL, PS1 NTF, PS1 CTF, and Pen-2 in total protein extracts
from parental and Syt1 KD PC12 cells (n = 4 for PS1 FL, n = 8 for PS1 NTF and PS1 CTF, n = 7 for Pen-2). The intensities of the bands were normalized
to β actin levels. c Cell-free γ-secretase activity assay using parental and Syt1 KD PC12 cell membrane preparations and recombinant C100-FLAG as a
substrate. The amounts of Aβ40 and Aβ42 were determined by sandwich ELISA and normalized to the levels of PS1 CTF in the corresponding samples.
The intensities of AICD-FLAG bands were measured by densitometry and normalized to PS1 CTF. The quantitative data in all panels are presented as
mean ± SEM, n = 4. Statistical significance was determined using the unpaired student t-test, * p < 0.05, ** p < 0.01. Syt1 synaptotagmin, Aβ amyloid β,
AICD APP intracellular domain, APP amyloid precursor protein, PS1 presenilin 1, NTF N-terminal fragment, Pen-2 presenilin enhancer 2, IP immunoprecip-
itation, CTF C-terminal fragment, FL full length
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stability of PS1 CTF and APP between parental and Syt1
KD cells was observed (Additional file 4).
Syt1 affects localization of APP processing enzymes
To determine whether Syt1 may modulate Aβ production
by influencing trafficking of BACE1, PS1/γ-secretase, or
APP, we analyzed their distribution in the parental and
Syt1 KD PC12 cells using subcellular fractionation
(Fig. 12a). We found that lack of Syt1 affects trafficking of
PS1 CTF and BACE1 but not APP. The PS1 CTF has been
retained within the earlier secretory compartments in Syt1
KD cells. On the other hand, the distribution of BACE1
has shifted towards the trans-Golgi network in the ab-
sence of Syt1.
The cell-surface biotinylation approach revealed a sig-
nificantly reduced amount of BACE1 and PS1 CTF on
the surface of Syt1 KD cells as compared to parental
PC12 cells (Fig. 12b). However, since the levels of ma-
ture, functionally active γ-secretase (PS1 CTF/NTF) and
BACE1 were considerably reduced in the absence of
Syt1, we calculated the ratio of plasma membrane to
total level for each of the proteins. The adjusted values
were not significantly different between the cell lines,
although there was a trend towards reduced PS1 CTF
plasma membrane/total ratio in Syt1 KD cells, suggest-
ing that the impaired intracellular transport of PS1
might cause this slight reduction of the PS1/γ-secretase
at the cell surface.
To determine if the observed mislocalization of PS1
and BACE1 in the absence of Syt1 was due to a broader
effect of the Syt1 KD on protein trafficking, we analyzed
subcellular distribution of another synaptic protein, synap-
tophysin (Syp), as well as other γ-secretase members/
transmembrane proteins, Nct and Pen-2, in Syt1 KD and
parental PC12 cell lines (Additional file 5A and B bottom
panel). No major differences in the abundance of the
target proteins within the respective fractions were ob-
served between the cell lines. Furthermore, the overall
transport fidelity was not noticeably altered by the lack of
Syt1, as shown by comparable distribution of the compart-
ment specific markers within the respective fractions in
PC12 cells with and without Syt1 (Additional file 5B). This
further reaffirms that Syt1 selectively affects PS1 and
BACE1, and that their misdistribution is not due to
impairments in the overall intracellular transport fidelity
in the Syt1 KD cells.
Syt1 is unlikely a substrate for PS1/γ-secretase
Since Syt1 has a relatively short N terminus, single-pass
transmembrane domain and a larger cytoplasmic region,
a structure similar to the previously known PS1/γ-secre-
tase substrates, we tested if Syt1 may be a novel γ-
secretase substrate. There was no difference in the levels
of Syt1 and its proteolytic fragments between DMSO-
and γ-secretase inhibitors-treated primary neurons and
mouse embryonic fibroblasts (MEF), or in MEFs lacking
Fig. 9 Notch1 intracellular domain (NICD) generation is not affected in Syt1 KD PC12 cells. Parental and Syt1 KD PC12 cells were transfected with
Myc-tagged, constitutively active Notch1 with deleted extracellular domain (NΔECD), which is an immediate substrate of the γ-secretase. The cells
were treated with DMSO or γ-secretase inhibitor — DAPT. Transfection with a plasmid encoding Notch1 intracellular domain (NICD) was used as
a control. Western blot analysis shows no difference in the production of the Notch1 intracellular domain, as detected by anti-myc antibody,
between parental and Syt1 KD PC12 cells. Data are presented as the NICD/NΔECD ratio; mean ± SEM, n = 4. Statistical significance was determined
using unpaired student t-test. Syt1 synaptotagmin 1
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PS1/PS2 (Additional file 6). Hence, it is unlikely that
Syt1 is a PS1/γ-secretase substrate.
Discussion
Synaptotagmin 1 (Syt1), a synaptic vesicle associated
protein, was identified as a novel Ca2+-dependent bind-
ing partner of presenilin 1 (PS1). Moreover, a new role
of Syt1 in modulation of the PS1 conformation and Aβ
production via several mechanisms was revealed.
The Ca2+-dependent profile of PS1 binding to Syt1 sug-
gests that Ca2+ may function as a switch controlling PS1
interaction with the synaptic vesicle (SV) protein intimately
involved in SV exocytosis and neurotransmitter release. An
involvement of presenilins in the activity-dependent regula-
tion of neurotransmission was shown by Zhang et al. [30],
reporting Ca2+-linked impairment of synaptic facilitation
and neurotransmitter release as a result of selective pre-
but not post-synaptic inactivation of PS1/2. Together, these
findings suggest that PS1 may be involved in regulation of
the neurotransmitter release via Ca2+-triggered interaction
with Syt1. In addition, our study shows that since presynap-
tic terminals are the major sites of the Ca2+-induced inter-
action in neurons, as determined by FLIM (Fig. 5b), Syt1
might play a role in modulation of the Aβ production/se-
cretion locally at the synaptic terminals. This does not,
however, exclude the role of Syt1 in Aβ production away
from the synapse and/or in a PS1-independent manner.
Synaptic activity and Ca2+ flux are tightly linked to Aβ
production [11–13, 31] but the molecular mechanisms
underlying modulation of the Aβ production at the syn-
apse remain elusive. A sustained release of the neurotoxic
Aβ42 species in response to stimulation of isolated nerve
terminals [21], and deposition of oligomeric Aβ at the
excitatory synapses in the brain were reported [32, 33].
The formation of Aβ oligomers and their neurotoxicity
depends not only on the increased amount of Aβ but
more importantly on the Aβ42/40 ratio [34]. Familiar AD
causing mutations in PS1, PS2, or APP consistently in-
crease the relative ratio between the Aβ42 and Aβ40 pep-
tides, irrespective of the individual levels of Aβ42 and
Fig. 10 APP CTF and sAPPβ production are reduced in the absence of Syt1. Western blot analysis of the APP processing in PC12 (a endogenous APP)
and CHO (b stably overexpressed human APP) cells. The levels of sAPPβ, sAPPα, and APP CTFs (total) were normalized to FL APP. Data are presented as
mean ± SEM, (A) n = 6 for APP CTF and n = 8 for sAPPβ, (B) n = 7 for APP CTF, n = 6 for sAPPα, n = 5 for sAPPβ. Statistical significance was determined
using the unpaired student t-test, * p < 0.05, ** p < 0.01, *** p < 0.001. APP amyloid precursor protein, sAPPβ secreted APPβ, Syt1 synaptotagmin 1, CHO
Chinese hamster ovary cells, CTF C-terminal fragment, FL full length
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Aβ40 [35–37]. We have previously reported that increased
Aβ42/40 ratio is tightly linked to pathogenic “closed” con-
formation of PS1 [22, 23, 25, 38]. Concomitant with these
findings, our current study demonstrates that continuous
neuronal activation and elevated intracellular calcium
induce pathogenic “closed” conformation of PS1, and pro-
vide a mechanistic explanation of the observed targeted ac-
cumulation of Aβ oligomers at the synapse.
Structural changes in PS1 are observed during normal
aging, they precede Aβ plaque deposition, and are
Fig. 11 Syt1 modulates BACE1 maturation and stability. a Levels of total and immature BACE1 in protein lysates from parental and Syt1 KD PC12
cells were determined by western blotting using anti-BACE1 antibodies directed against the C-terminus or prodomain of BACE1, respectively (n = 5).
The specificity of the antibodies was confirmed using overexpression of human BACE1 in CHO cells (top gel) and brain lysates from BACE1 KO and
control littermate mice (bottom gel). The intensities of all BACE1 bands were quantified by densitometry and normalized to the levels of β actin. Data
are presented as mean ± SEM. Statistical significance was determined using unpaired student t-test. ** p < 0.01, *** p < 0.001. b Analysis of BACE1
degradation. Parental and Syt1 KD PC12 cells were treated with cycloheximide and harvested 0, 2, 4, 8, 24, and 48 hours after the treatment
(n = 5). Western blot presents BACE1 expression over time. Anti-BACE1 C-terminal antibody was used for detection. The quantitative analysis of BACE1
levels revealed a significantly reduced half-life of BACE1 in Syt1 KD PC12 cells compared to the parental PC12 control (marked with black dashed lines).
Statistical significance was determined using 2-way ANOVA with Bonferroni post-test, *** p < 0.001
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exacerbated in sporadic AD brains [39]. We propose that
PS1/γ-secretase exists in a dynamic equilibrium of different
conformational states, which we call “closed” and “open”
based on the FRET measurements, that may modulate PS1
function [23, 25]. Although it is possible that familial AD
(fAD) mutations in PS1 [23] or recruitment of Aph1B
isoform [38] produce more stable γ-secretase complexes
with PS1 in pathogenic “closed” conformation, our current
study shows that allosteric changes in the pre-existing γ-
secretase complexes can occur in response to Ca2+. Import-
antly, these changes are reversible, as shown after a brief
puff of glutamate, and closely correlate with the cytosolic
Ca2+ level. We demonstrate that in addition to promoting
“closed” PS1 conformation, prolonged depolarization of
neurons and continuing high intracellular Ca2+ also in-
creased the level of both Aβ40 and Aβ42 and, importantly,
led to an increased Aβ42/40 ratio. These data are consistent
with Kim et al. [21] reporting a similar increase in Aβ42
levels after KCl-induced depolarization of isolated nerve
terminals, synaptoneurosomes, and are in line with the
early detection of Aβ deposits in the default mode network
of asymptomatic older adults [10]. Interestingly, a spike-
burst stimulation of hippocampal neurons increased release
of only Aβ40 but not Aβ42, accompanied by PS1 conform-
ational changes consistent with reduced FRET efficiency
[40]. These data suggest that diverse stimuli and/or their
duration may have different outcomes, with continued acti-
vation and/or persistent high calcium inducing pathogenic
change in PS1/γ-secretase and elevated Aβ42/40 ratio that
would ultimately lead to Aβ deposition in the brain.
Our current study reveals that Syt1 may be required
for the maintenance of the physiological “open” PS1
conformation, as pathogenic conformational change of
PS1 was detected in the absence of Syt1. Consistent with
the PS1 conformational change, the ratio of Aβ42 to
Aβ40 was elevated in Syt1 KD cells, although the level
of both Aβ40 and Aβ42 was significantly reduced in the
absence of endogenous Syt1 and increased by transient
Syt1-V5 overexpression. This is consistent with our find-
ings in stably Syt1 transfected PC12 and CHO cells [41].
Fig. 12 Subcellular compartmentalization of PS1, APP, and BACE1 in the presence and absence of Syt1. a Western blots show distribution of PS1,
APP, and BACE1 in 13 subcellular fractions from parental and Syt1 KD cells. The arrows indicate a shift in the subcellular distribution in Syt1 KD cells. The
enrichment of the respective subcellular compartments was determined by western blotting with anti-calreticulin, anti-GM130, anti-Tgn46, and anti-Rab11
antibodies. The fractions that correspond to the respective intracellular compartments are indicated above the western blots. b Bar graphs
present quantitative analysis of the PS1, APP, and BACE1 levels at the plasma membrane, in total protein lysates, and the ratio of plasma
membrane/total protein. Data are presented as mean ± SEM, n = 4 for PS1 in the membrane fraction, n = 8 for PS1 in total lysate, n = 5 for APP,
and n = 5 for BACE1. Statistical significance was determined using the unpaired student t-test, * p < 0.05, ** p < 0.01; ***p < 0.001. PS1 presenilin
1, APP amyloid precursor protein, BACE1 β-secretase 1, Syt1 synaptotagmin 1
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Interestingly, whereas KCl treatment induced PS1 con-
formational change and triggered Aβ production in neu-
rons and parental PC12 cells, it had no effect on either
in Syt1 KD cells. Thus, it is highly likely that in addition
to its role in exocytosis, Syt1, presenting a strong and
specific synaptic expression pattern in neurons, may also
modulate Aβ production/secretion locally at the synaptic
terminals.
We identified several molecular mechanisms that under-
lie Syt1-mediated regulation of Aβ, both PS1 interaction-
dependent and independent. Syt1 and its interaction with
PS1 may be needed for maintaining PS1 in the “open” con-
formation, and modulation of specific Aβ species pro-
duced. We observed tighter association of the γ-secretase
components (consistent with the “closed” PS1 conform-
ation), diminished amount of PS1 NTF/CTF, and reduced
γ-secretase activity in Syt1 KD compared to parental cells,
indicating that architecture and activity of the γ-secretase
complex are impaired in the absence of Syt1. Importantly,
whereas Aβ production was reduced by Syt1 KD, the PS1/
γ-secretase dependent epsilon and S3 cleavages, respon-
sible for AICD and NICD generation, respectively, were
not affected. This finding is consistent with the step-wise
γ-secretase cleavage model that proposes a three amino
acid spaced cleavage mechanism for γ-secretase mediated
intramembrane proteolysis [28, 29, 42]. The effect of Syt1
KD is also in agreement with the proposed γ-secretase
loss-of-function due to familial AD mutations in PS1,
which also display “closed” conformation and biochem-
ically result in a partial loss of the γ-secretase activity due
to inability of ‘complete digestion’ of the APP substrate,
generating fewer but longer Aβs (for review see [37]).
Calcium binding to Syt1 activates SV release machin-
ery [18] and, hence, may promote exocytosis of Aβ at
the synapse. Indeed, active PS1/γ-secretase complex,
APP and BACE1 were found in SVs enabling Aβ produc-
tion within the vesicles ([43–47] and this study).
Moreover, we found that Syt1 knockdown selectively
impairs intracellular trafficking of PS1 and BACE1 and,
thus, may affect Aβ via trafficking abnormalities and
away from the synapse. Syt1 is also a direct binding part-
ner of APP [41, 48] and, therefore, may regulate APP
processing by acting as a chaperon for APP and/or PS1,
influencing their subcellular localization, alignment and
interaction. Indeed, our FLIM assay revealed diminished
APP-PS1 proximity in the absence of Syt1, which could
be due to observed mislocalization of PS1 in the Syt1
KD cells. Finally, we demonstrate that Syt1 expression is
crucial for localization, maturation, and stability of
BACE1; thus, it may also modulate earlier steps of the APP
processing. We found that the subcellular localization of
BACE1 but not APP is altered in the absence of Syt1. This
is consistent with other studies showing that trafficking of
APP and BACE1, namely surface-to-endosome transport
and sorting, could be distinctly regulated within the cell
[49–51]. It should also be mentioned that since PS1 is in-
volved in BACE1 maturation [52], there is a possibility that
affected PS1 function in Syt1 KD has a downstream effect
on BACE1.
Taken together these findings provide compelling evi-
dence supporting a role of Syt1 in Aβ production.
Namely, in addition to facilitation of the Aβ secretion
via exocytosis, Syt1 plays a direct role in the activity-
mediated regulation of APP processing by: (1) modulat-
ing PS1/γ-secretase conformation, catalytic activity, and
interactions with APP; (2) affecting BACE1 maturation
and stability; and (3) mediating BACE1 and PS1 subcel-
lular compartmentalization.
The discovery of the novel Ca2+-dependent interactions
between PS1 and Syt1 links several well-established
players implicated in AD pathogenesis, such as elevated
Ca2+, structural changes in PS1/γ-secretase, and toxic
Aβ42 specie generation with synaptic proteins critical for
SV/neurotransmitter release. It also provides strong evi-
dence for Syt1 being a Ca2+-sensitive modulator of the
PS1/γ-secretase, APP processing, and consequent Aβ pro-
duction and deposition at the pre-synapse, suggesting a
new role for Syt1 in neurodegeneration. Lack of the Syt1
effect on Notch1 ICD generation may encourage novel
synapse-specific therapeutic strategies targeting Syt1-PS1
interaction.
Conclusions
Synaptic loss caused by local accumulation of the oligo-
meric amyloid β (Aβ) is the strongest and the earliest
correlate of Alzheimer’s disease dementia. However,
events and proteins that influence synaptic Aβ accumu-
lation are poorly understood. In a search for early modi-
fiers of the synaptic Aβ we identified synaptic protein,
synaptotagmin 1 (Syt1), as a novel calcium-regulated
interactor of the Aβ cleaving enzyme, presenilin 1 (PS1)/
γ-secretase. We found that Syt1 may function as
activity-dependent regulator of the synaptic Aβ by
modulating PS1 catalytic activity and conformational
state, BACE1 maturation and stability. These novel dis-
coveries provide a mechanistic link between major
players implicated in AD pathogenesis: high calcium,
toxic Aβ42 specie, PS1/γ-secretase conformational
changes, and synapse. Furthermore, these findings may
open avenues for new, synapse-targeting therapeutic
strategies to halt the Alzheimer’s disease progression.
Methods
Expression plasmids
The GFP-PS1-RFP (G-PS1-R) construct encoding wild
type (wt) human presenilin 1 (PS1) with enhanced green
fluorescent protein (EGFP) fused to the N-terminus and
red fluorescent protein (RFP) inserted into the loop
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domain of PS1 was used for the fluorescence life time
imaging (FLIM) assay of PS1 conformational changes
[25]. The constructs with EGFP fused to the N-terminus
of PS1 (G-PS1), RFP inserted into the loop domain of
PS1 (PS1-R), and RFP-GFP fusion (R-G fusion) plasmid,
in which RFP is fused to the N-terminus of EGFP with a
short linker, were used as controls.
Human wt synaptotagmin 1 (Syt1) was cloned into
pcDNA™ 6 V5 Myc expression vector (Life Technologies,
Grand Island, NY). Mutations that affect calcium bind-
ing to Syt1 (D230A, D309A, and D365A) were intro-
duced using a QuickChange site-directed mutagenesis
kit (Stratagene, La Jolla, CA) to generate Syt1 3D-A
plasmid. The empty pcDNA™ 6 V5 Myc vector was used
as a control.
pCS2 Notch1 ΔEC-6MT vector encoding C-terminally
Myc-tagged and N-terminally truncated Notch 1 receptor
construct (NΔECD), which does not require ligand bind-
ing for its activation and represents an immediate sub-
strate of γ-secretase, and pCS2 Notch1 ICD-6MT plasmid
encoding the intracellular domain of murine Notch1
(NICD) were gifts from Dr. R. Kopan (Washington
University, St. Louis).
GST protein cloning, purification, and LC-MS/MS analysis
The protocol used for GST protein cloning and purifica-
tion was adapted from [53]. Briefly, DNA fragments
encoding human presenilin 1 N-terminus (PS1 NT)
(amino acids 1–80), PS1 loop 1–2 (amino acids 98–134),
and PS1 loop 6–7 (amino acids 263–376) were sub-
cloned into the glutathione S-transferase (GST) expres-
sion vector pGEX-6P-2 (GE Healthcare Life Sciences,
Pittsburgh, PA) to create corresponding PS1 fragment-
GST fusion peptides. For GST protein purification,
Escherichia coli BL21 (fhuA2 [lon] ompT gal [dcm]
ΔhsdS) cells were transformed with the plasmids and the
protein expression was induced by the addition of 1 mM
isopropyl-D-thiogalactoside (IPTG). The bacterial cul-
tures were centrifuged at 3500 xg for 20 minutes at 4 °C,
the pellet was resuspended in TBST and the bacterial
suspensions were sonicated. The lysates were clarified by
centrifugation at 14,000 xg for 15 minutes at 4 °C, and
then incubated with washed glutathione-Sepharose 4B
beads.
Mouse brain lysates prepared in 1 % Triton X-100 ice-
cold lysis buffer (see below) were used for MS analysis.
The soluble supernatant fraction was divided into equal
aliquots that were incubated with GST-PS1 peptides,
immobilized on a column in Ca2+-free or 2 mM CaCl2
conditions. The recombinant GST peptide was used as a
control. The bound proteins were eluted with 2xSDS
NuPage sample buffer (Life Technologies, Grand Island,
NY) and separated by electrophoresis using 4–12 %
1.5 mm Bis-Tris NuPage gels (Life Technologies, Grand
Island, NY). The gels were stained with coomassie blue
stain (Life Technologies, Grand Island, NY), and several
bands that displayed differential protein profile between
GST-control and GST-PS1 pull-down, between GST-PS1
pull-down from brain lysates vs. lysis buffer, and be-
tween the Ca2+(+) and Ca2+(-) conditions were excised,




Brain cortices were dissected from 2- to 3-month-old
wild type (wt) CD1 mice (Charles River Laboratories,
Wilmington, MA) and homogenized in a buffer con-
taining 50 mM HEPES, 125 mM NaCl, 0.1 mM EDTA,
100 mM sucrose, protease inhibitors (Roche, Indian-
apolis, Indiana) and 1 % Triton X-100 (Tx-100) or 1 %
3-[(3-cholamidopropyl) dimethylammonio]-2-hydroxy-
1-propanesulfonate (CHAPSO)). Brain lysates were in-
cubated for 1 hour at 4 °C and centrifuged at 14,000xg
to collect the soluble fractions, which were subjected to
mass spectrometry (MS), immunoprecipitation (IP) and
western blot analyses. All experiments that involve use
of the mouse brain tissue were approved by the Subcom-
mittee for Research Animal Care at the Massachusetts
General Hospital.
Synaptoneurosome (SNS) extraction
SNSs were isolated as described previously [54] with minor
modifications. In brief, cortices from 3-month-old CD1
male mice were mechanically homogenized in 1.5 ml ice
cold buffer A (25 mM HEPES, 120 mM NaCl, 5 mM KCl,
1 mM MgCl2) supplemented with 2 mM dithiothreitol
(DTT), protease inhibitor (Roche, Indianapolis, Indiana),
and phosphatase inhibitor cocktails 2 and 3 (Sigma-
Aldrich, St. Louis, MO). Samples were filtered through
two layers of 80 μm nylon filters (Millipore, Temecula,
CA) to remove cellular debris. A total of 200 μl from
each sample was saved, mixed with 200 μl water and
70 μl 10 % SDS, passed through a 27-gauge needle,
and boiled for 5 minutes to be used as a total extract.
The remaining homogenates were filtered through a 5 μm
Supor membrane filter (Pall Corp., Port Washington, NY)
to remove large organelles and nuclei, and the filtrates
were centrifuged at 1000xg for 10 minutes to pellet SNSs.
The pellets were resuspended in buffer A and used for
immunostaining or were lysed in buffer B (50 mM Tris,
1.5 % SDS, and 2 mM DTT) and used for immunoprecipi-
tation and western blotting.
Antibodies
The following primary antibodies were used: anti-PS1 NT
raised against the N-terminus of human PS1 (H-70, sc-
7104, Santa Cruz Biotechnology, Santa Cruz, CA, and
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MAB1563, Millipore, Temecula, CA); anti-PS1 CT raised
against the C-terminus of human PS1 (D3901, Cell Signal-
ing Technology, Danvers, MA); anti-PS1 loop raised
against the loop domain between transmembrane domains
6 and 7 of human PS1 (2094-1, Epitomics, Burlingame,
CA, and MAB5232, Millipore, Temecula, CA); ASV30
anti-synaptotagmin 1 (Syt1) raised against rat brain synap-
tic junctional complexes (MA125568, Pierce, Rockford, IL);
anti-Syt1 raised against the C-terminus of rat Syt1
(MAB5200, Millipore, Temecula, CA); anti-V5 (R960-25,
Life Technologies, Grand Island, NY); anti-FLAG (F1804,
Sigma-Aldrich, St. Louis, MO), anti-synapsin 1 (Syn1)
(D12G5, Cell Signaling Technology, Danvers, MA); anti-
nicastrin (PRS3985, Sigma-Aldrich, St. Louis, MO); anti-
Pen-2 (P5622, Sigma-Aldrich, St. Louis, MO); anti-Aph1aL
(PRB-550P, Covance, Dedham, MA); anti-amyloid precur-
sor protein (APP) CT (A8717, Sigma-Aldrich, St. Louis,
MO); anti-APP NT (MAB348, Millipore); anti-sAPPβ
(18957, IBL America, Minneapolis, MN); anti-APP (597)
(28055, IBL America, Minneapolis, MN); APP C66 (cus-
tom); anti-BACE1 (D10E5, Cell Signaling Technology,
Danvers, MA); anti-BACE1 raised against the prodomain
(LS-C51629, LifeSpan Biosciences, Seattle, WA); anti-actin
(4968, Cell Signaling Technology, Danvers, MA), anti-Na
+/K+ ATPase (AB7671, Abcam, Cambridge, MA); anti-
Rab11 (610656, BD Biosciences); anti-Tgn46 (AB16059,
Abcam, Cambridge, MA); anti-GM130 (610822, BD Bio-
sciences, San Jose, CA); anti-calreticulin (612136, BD Bio-
sciences, San Jose, CA), anti-GFP (632380, Clontech,
Madison, WI), and anti-Myc (MA1-980, Pierce, Rockford,
IL). Alexa Fluor 488 and Cy3-labeled corresponding sec-
ondary antibodies (Life Technologies, Grand Island, NY)
were used for confocal microscopy imaging, and horserad-
ish peroxidase (HRP)-conjugated ones (Pierce, Rockford,
IL) for western blotting.
Immunoprecipitation and western blotting
Hippocampal brain tissue from wt 3-month-old male
CD1 mice was homogenized in 9 volumes of 1 %
CHAPSO buffer (50 mM HEPES, 100 mM NaCl, pH 7.1
and 1 % CHAPSO) using plastic pestle homogenizers.
Pelleted SNS fractions from wt mice brain cortex and
cultured cells were homogenized by pipetting in 1 %
CHAPSO or 1 % Tx-100 buffer (50 mM HEPES,
100 mM NaCl, pH 7.4, and 1 % Tx-100) and then pass-
ing through a 27-gauge needle. All lysis buffers were
supplemented with HALT protease and phosphatase
inhibitor cocktails (Fisher, Pittsburg, PA). The homoge-
nates were rotated at 4 °C for 1 hour, centrifuged at
20,000xg for 20 minutes and the supernatants were col-
lected as samples for IP. Total protein concentrations
were determined by Thermo Scientific™ Pierce™ BCA™
Protein Assay (Pierce, Rockford, IL).
Aliquots of the supernatant containing equal amounts
of total protein were incubated with anti-PS1 NT, anti-
PS1 CT, anti-PS1 loop, or anti-Syt1 antibodies overnight
at 4 °C with end-over-end rotation. Normal rabbit IgG
or mouse anti-FLAG antibodies were used as negative
controls. After the overnight incubation, 20–30 μl of Pro-
tein G Dynabeads (Life Technologies, Grand Island, NY)
were added to each sample and incubated for 10 minutes
at room temperature. The Dynabeads were collected and
washed twice with 1 % CHAPSO buffer and once with
wash buffer (50 mM HEPES, 100 mM NaCl, pH 7.4) or
three times with 1 % Tx-100 buffer. Bound proteins were
eluted by boiling at 95 °C for 5 minutes with 2xLDS
sample buffer (Life Technologies, Grand Island, NY)
containing 4 % β-mercaptoethanol.
Immunoprecipitated or total protein was separated by
SDS-PAGE on 4–12 % or 10 % Bis-Tris NuPage poly-
acrylamide gels (Life Technologies, Grand Island, NY).
After the electrophoresis, protein was transferred to
nitrocellulose membranes (GE Healthcare Lifesciences,
Pittsburgh, PA) and probed with respective primary and
corresponding HRP-conjugated secondary antibodies.
The blots were developed using ECL Western Blotting
Substrate (Pierce, Rockford, IL) and exposed on X-ray films
(Amersham Hyperfilm ECL). The intensity of respective
protein bands was quantified using ImageJ 1.46c software.
When necessary, antibodies were stripped using One
Minute WB Advance Stripping Buffer (GM Biosciences,
Rockville, MD).
Cell cultures and transfection
Primary neuronal cultures were obtained from 16- to
18-day-old embryos of CD1 wild-type mice. Cortical and
hippocampal neurons were extracted using a Papain
Dissociation Kit (Worthington Biochemical Corporation,
Lakewood, NJ) and plated onto tissue culture grade
dishes and slides coated with poly-D-lysine. Cells were
cultured for 12–28 days in vitro (DIV) in Neurobasal
Media supplemented with 2 % B27 supplement, 1 % peni-
cillin/streptomycin, 1 % Glutamax (Life Technologies,
Grand Island, NY) in 37 °C, 5 % CO2 incubator.
Rat pheochromocytoma cell line (PC12) stably ex-
pressing short hairpin RNA (shRNA) specifically silen-
cing the expression of Syt1, referred to as Syt1 KD
PC12, and the parental PC12 cell line were kindly pro-
vided by Dr. Amy B. Harkins (St. Louis University
School of Medicine) [55]. The cells were grown in RPMI
Medium 1640 supplemented with 10 % heat-inactivated
horse serum, 5 % fetal bovine serum (FBS), and 1 %
penicillin/streptomycin (Pen/Strep) (Life Technologies,
Grand Island, NY) in a 37 °C, 5 % CO2 incubator. For
biochemical or microscopy (optical imaging) analyses, they
were plated into 10 cm Petri dishes (Becton Dickinson
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Labware, Franklin Lakes, NJ) or 35 mm glass-bottom cul-
ture dishes (MatTek Corp, Ashland, MA), respectively.
When needed, cells were transfected with selected expres-
sion plasmids using Lipofectamine LTX and Plus reagents
(Life Technologies, Grand Island, NY).
PS double-knockout (PS-/-) mouse embryonic fibro-
blasts (MEF) and PS-/- stably transfected with wt hu
PS1 were provided by Dr. B. De Strooper (Belgium).
Chinese hamster ovary (CHO) cell lines expressing hu-
man wt APP and PS1 (PS70) were gifts from Dr. Selkoe
(Boston, MA). CHO cells stably expressing human wt
APP and Syt1-V5 were generated in Dr. Kovacs lab
(Boston, MA). All the cell lines were cultured in Opti-
MEM® I Reduced Serum medium supplemented with
5 % FBS (Life Technologies, Grand Island, NY), and
respective selection antibiotics in a 37 °C, 5 % CO2 in-
cubator. When necessary, the cells were transfected
with other expression plasmids using Lipofectamine
LTX (Life Technologies, Grand Island, NY).
Spectral Förster resonance energy transfer (FRET)
Primary neurons (12–14 days in vitro [DIV 12–14]) were
cultured in phenol red-free culture medium and trans-
fected with G-PS1-R expression plasmid as a reporter of
PS1 conformational changes, or G-PS1, R-PS1, and G-R
fusion constructs as controls for determining spectral
FRET settings using Metadetector on a Zeiss LCM510
microscope as described [25]. For the time-lapse record-
ing, neurons were imaged twenty-four hours after the
transfection with G-PS1-R. An argon laser at 488 nm
was used to excite GFP, and emitted fluorescence was de-
tected within 513 ± 10.57 nm (GFP) and 598 ± 10.57 nm
(RFP) spectral bandwidth of the Metadetector [25]. The
fluorescence signal was recorded every ~30 seconds using
a Zeiss LCM510 microscope equipped with 37 °C, 5 %
CO2 incubation chamber.
The G-PS1-R transfected neurons were imaged for 5 mi-
nutes to set up the baseline RFP/GFP ratio. Then, 100 μl
of 50 mM KCl or H2O were added directly into the dish
or 10 μl of 1 M L-glutamate (Glu) (Sigma-Aldrich, St.
Louis, MO) were squirted directly onto imaged neuron,
and changes in the fluorescence intensity were recorded
for up to 60 (KCl) or 15 (Glu) minutes post-treatment. In
the control experiment, to prevent Ca2+ influx into the
Glu-treated neurons, culture medium was replaced with
Hanks Balanced Salt Solution without Ca2+ and Mg2+
(Life Technologies, Grand Island, NY).
The acquired images were analyzed using LSM Image
Browser. A ratio of 598 nm (RFP) to 513 nm (GFP) was
used as readout of the FRET efficiency (%EFRET) (R/G
ratio), which reflects relative proximity between the RFP
and the GFP fluorophores. A ratiometric pseudo-color
image was produced using ImageJ 1.46c software, by div-
iding the average pixel fluorescence intensity of an image
in the 598 nm spectral window by that in the 513 nm
window, after subtracting the background fluorescence.
The Look-Up Table (LUT) was applied by mapping
image values to color-scale (16 colors) resulting in the
pseudo-color image.
Calcium imaging
To measure changes in intracellular Ca2+ levels, primary
neurons were pre-loaded with 5 μM Oregon Green 488
BAPTA-1 AM (Life Technologies, Grand Island, NY)
and imaged before and after KCl or Glu treatment. The
images were captured every 3.95 seconds using time-
lapse settings, following an excitation with a 488 Argon
laser. The average intensities of the Oregon Green 488
BAPTA-1 AM pre-loaded cells were measured using
ImageJ 1.46c software. The fluorescence intensities of
the cells recorded after the treatment were normalized
to the pre-treatment ones, after background fluorescence
subtraction.
Immunocytochemistry
Primary neurons were fixed in 4 % PFA, permeabilized in
0.1 % Tx-100 with 1.5 % normal donkey serum (Jackson
ImmunoResearch Labs, West Grove, PA), and incubated
overnight at 4 °C with the following primary antibodies:
goat anti-PS1 loop and mouse anti-Syt1 for the PS1-Syt1
proximity assay and rabbit anti-APP CT and mouse anti-
PS1 loop for the PS1-APP interaction assay. Correspond-
ing Alexa Fluor 488- or Cy3-labeled secondary antibodies
were added for 1 hour at room temperature before
mounting the coverslips with VectaShield mounting
medium (Vector Laboratories, Inc., Burlingame, CA).
Fluorescent lifetime imaging microscopy (FLIM)
The proximity between fluorophore labeled endogenous
PS1 and Syt1, PS1 and APP, or PS1 NT and CT was evalu-
ated by a previously validated FLIM assay [22, 56]. Briefly,
pulsing Chameleon Ti:Sapphire laser (Coherent Inc., Santa
Clara, CA) was used to excite Alexa Fluor 488 donor
fluorophore (two-photon excitation at 780 nm wave-
length). The baseline lifetime (t1) of the Alexa Fluor 488
fluorophore was measured in the absence of the Cy3 ac-
ceptor fluorophore (negative control, FRET absent). Donor
fluorophore lifetimes were recorded using a high-speed
photomultiplier tube (MCP R3809; Hamamatsu, Bridge-
water, NJ) and a fast time-correlated single-photon
counting acquisition board (SPC-830; Becker & Hickl,
Berlin, Germany). In the presence of the acceptor
fluorophore, excitation of the donor fluorophore yields
reduced donor emission energy if the donor and the
acceptor are less than 5–10 nm apart (FRET present).
This results in a characteristic shortening of the donor
fluorophore lifetime (t2). The acquired FLIM data
were analyzed using SPC Image software (Becker &
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Hickl, Berlin, Germany). The %EFRET was calculated
using the following equation: %EFRET = 100*(t1-t2)/t1
[57]. The degree of the donor fluorophore lifetime
shortening (or increase in the %EFRET) correlates with
the increase in the proximity between the PS1 NT and
CT, or PS1 and either Syt1 or APP molecules.
Immunoelectron microscopy
Adult CD1 mice were perfused with 4 % paraformalde-
hyde (PFA) before the cortices were excised and 1 mm-
thick slices were fixed in a mixture of 0.1 % tetroxide,
dehydrated, and embedded in araldite/dodecynyl succinic
anhydride (DDSA) resin (Electron Microscopy Sciences,
Hatfield, PA). Then, 70 nm-thick sections were cut on an
ultracut microtome (Leica) and dried onto formar/car-
bon-coated mesh electron microscopy (EM) grids prior to
immunostaining with anti-PS1 C-terminal fragment pri-
mary antibody (Sigma, P7854), followed by 6 nm-Ag-par-
ticles labeled secondary antibody (Aurion). Grids were
negatively stained with 1 % filtered uranyl acetate in 70 %
ethanol. The samples were examined and the images
acquired using a JEOL 100S electron microscope (JEOL,
USA, Peabody MA).
ELISA for Aβ40 and Aβ42
To determine Aβ levels secreted into conditioned medium,
culture medium of each sample was replaced by an
equal amount of serum-free Advanced DMEM supple-
mented with 2 % GlutaMAX for PC12 cell lines and
fresh Neurobasal growth medium supplemented with
2 % GlutaMAX and 1 % B27 for mouse primary neu-
rons, respectively (Life Technologies, Grand Island,
NY). Aβ40 and Aβ42 levels were measured using hu-
man/rat Aβ40 and Aβ42 enzyme-linked immunosorb-
ent assay (ELISA) kits (Wako, Japan) according to the
manufacturer’s instructions. Each value recorded in
ELISA was normalized to the protein concentration of
the corresponding cell extract measured with a BCA
protein assay (Pierce, Rockford, IL).
Cell-free γ-secretase assay
The crude homogenates of cellular membranes were
prepared from parental or Syt1 KD PC12 cells in 20 mM
HEPES (pH 7.4) containing protease inhibitor cocktail
(Roche, Indianapolis, IN). The lysates were centrifuged
at 3000xg for 15 minutes to remove cellular debris and
nuclei. The supernatant was collected and centrifuged
further at 100,000xg for 1 hour in a L8-80 M ultracentri-
fuge equipped with a Ti70.1 rotor (Beckman). Equal
amounts of 1 % CHAPSO-solubilized membranes were
incubated with C100-FLAG as a substrate (kindly pro-
vided by Dr. M.S. Wolfe, BWH, Boston, MA) for 4 hours
at 37 °C. After the incubation, the samples were placed
on ice to stop the reaction. For control purposes the
reaction was carried out at 4 °C or in the presence of γ-
secretase inhibitors.
Fractionation of subcellular membrane vesicles by
discontinuous OptiPrep density gradient
Preparation of total cellular membranes and subcellular
fractionation were based on procedures described previ-
ously [58] with minor modifications. In brief, parental or
Syt1 KD PC12 cells grown to confluence were washed
and harvested in cold HEPES buffer (25 mM HEPES,
150 mM NaCl, 1 mM DTT, 2 mM EGTA, pH7.4). Cellu-
lar pellets were resuspended in the HEPES buffer and
homogenized by passing through a 27-gauge needle.
Total cellular membranes isolated from parental or Syt1
KD PC12 cells were loaded on a step OptiPrep gradient of
10–30 % with 2.5 % increments and centrifuged in SW 41
Ti rotor (Beckman Coulter Life Sciences, Indianapolis,
IN) at 100,000xg at 4 °C for 16 hours. Then, 13 fractions
were collected from the bottom of each centrifuge tube
by puncture and equal amounts of the fractions were
subjected to SDS-PAGE and western blotting.
Cell surface protein isolation
Biotin-labeled cell surface proteins were isolated from
parental and Syt1 KD PC12 cells using a Thermo Scien-
tific™ Pierce™ Cell Surface Protein Isolation Kit (Pierce,
Rockford, IL). Briefly, cells grown to confluence in
collagen-coated dishes were incubated with sulfo-NHS-
SS-Biotin, dissolved in cold PBS, for 30 minutes at 4 °C.
After the incubation, the reaction was quenched by
adding a quenching solution.
The cells were collected, washed twice with TBS, and
lysed using a proprietary lysis reagent containing zwitter-
ionic detergent in 25 nM bicine buffer (pH7.6). The
biotin-labeled protein was isolated with NeutrAvidin agar-
ose by incubating the cell lysates with SDS-PAGE sample
buffer (Pierce, Rockford, IL) containing 50 mM DTT. All
the reagents, unless stated otherwise, were provided with
the kit. Protein concentration in each sample was deter-
mined using BCA Protein Assay (Pierce, Rockford, IL)
and equal amounts of protein were subjected to SDS-
PAGE and western blotting.
Cycloheximide (CHX) pulse-chase assay
Relative stability of the protein was estimated using a
CHX pulse-chase assay. Parental and Syt1 KD PC12
cells were treated with 20 μg/ml CHX (Sigma-Aldrich,
St. Louis, MO), diluted in the growth medium. The
cells were collected in 0, 2, 4, 8, 24, and 48 hours or 0,
15, 30, 45, and 90 minutes following the addition of
CHX, and sonicated in 1 % Tx-100 buffer (50 mM HEPES,
100 mM NaCl, pH7.4). The extracted proteins were ana-
lyzed by SDS-PAGE and western blotting. The intensity of
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each band was quantified using ImageJ 1.46c software and
normalized to the levels of a respective protein at 0 time
point. The data were plotted on the graph, fitted with a
one-phase decay curve, and analyzed with 2-way ANOVA
followed by multiple comparison Bonferroni post-test,
using GraphPad Prism 6 software.
Notch1 processing assay
Parental and Syt1 KD PC12 cells were transfected with
construct encoding Myc-tagged Notch1 with deleted
extracellular domain (NΔECD) or Myc-tagged Notch1
intracellular domain (NICD) as a control. To control for
the specificity of the γ-secretase activity assay, the cells
were treated for 12 hours with 500 nM γ-secretase
inhibitor, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phe-
nylglycine t-butyl ester (DAPT), or DMSO added to the
medium 12 hours after the transfection. Total protein
was extracted from the cells, resolved by SDS-PAGE,
and NΔECD and NICD were detected using anti-Myc
antibody (Pierce, Rockford, IL). The intensities of the
bands corresponding to NΔECD and NICD were quanti-
fied using ImageJ 1.46c software, and the NICD/NΔECD
ratio was compared between parental and Syt1 KD cells.
Statistics
To determine whether the R/G ratio in neurons treated
with either KCl or glutamate differs from the one in cells
treated with the vehicle control, a mixed model for the log
ratio with repeated measures and random effects was con-
structed and tested. Fixed effects were treatment, pre- vs.
post-treatment indicator, and the interaction between
them. Repeated measures over time employed a covariance
structure of first order auto-regressive moving average
(ARMA(1,1)). To allow for different baseline levels for indi-
vidual neurons, a random intercept was included in the
model. To answer the question whether the increased R/G
ratio in the cells treated with Glu actually goes back to the
baseline, we fitted a piecewise mixed linear model for the
treated group. This model includes linear components
broken down by the time interval points 0 to 5 (before
treatment), 5 to 6 (immediately after treatment) and 6 on
as fixed effects and random effects to allow different slopes
for individual cells and repeated measures with auto-
regressive covariance structure. In order to test a decrease
in the ratio back to pre-treatment levels, piecewise time
components were designed to test a non-zero slope. The
results from the model suggest a slope that is significantly
different from 0 for the interval point 5 to 6 (p-value
0.0001). The parameter estimate for this slope is positive,
which is in line with the hypothesized increase in the R/G
ratio between the time of treatment initiation and the time
point 6. The slope for the time interval point 6 on is also
significantly different from 0 (p-value 0.024) with a nega-
tive parameter estimate, suggesting again the hypothesized
decrease in R/G ratio. In addition, the initial time interval
in the model, which corresponds with the baseline pre-
treatment period, does not present with a slope signifi-
cantly different than 0, suggesting no trend in the ratio,
which is an expected outcome under no activity.
Statistical analysis of the FLIM data was performed
using StatView for Windows, Version 5.0.1 (SAS Institute,
Inc.). For quantitative western blotting, the intensities of
the bands corresponding to target proteins were measured
using ImageJ 1.46c software and compared between the
samples. Statistics were calculated with Microsoft Office
Excel 2007 or GraphPad® Prism 6 software using a two-
tailed unpaired student-test, Mann-Whitney’s U test or
2-way ANOVA with Bonferroni multiple comparison
post-test. P-value of < 0.05 was a predetermined thresh-
old for statistical significance. The data were recorded
from at least three different samples obtained on separate
days; n indicates biological replicates for each experiment.
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Availability of supporting data
The datasets supporting the conclusions of this article are
available in the IMEx consortium - IntAct [X] repository
[IM-25035] and included in the article as additional files.
Additional file 7 presents individual values recorded in the
experiments where n < 6. (XLSX 270 kb)
Additional files
Additional file 1: Spectral FRET analysis of the GFP and RFP intensities.
Primary neurons were transfected with GFP-PS1 (negative FRET control,
n = 12 cells), RFP-GFP fusion (R-G, positive FRET control, n = 24) or GFP-
PS1-RFP (PS1 conformation FRET probe, n = 10). The GFP was excited by
argon laser at 488 nm wavelength, and the emission intensities of GFP and
RFP within the 513 ± 10.57 nm and 598 ± 10.57 nm spectral bandwidth of
the Metadector, respectively, were collected every 3 minutes for the duration
of 33 minutes (middle and bottom graphs, respectively). The arrow indicates
the time point of 50 mM KCl stimulation. No significant change in the GFP or
RFP fluorescence emission intensity (no photobleaching), or the R/G ratio was
observed in the G-PS1 and R-G transfected cells. The change in the R/G ratio
after KCl stimulation was detected only in G-PS1-R transfected cells due to in-
creased FRET efficiency/change in PS1 conformation. The black line shows
mean ± SEM values. (TIF 1663 kb)
Additional file 2: Proteins identified in mass spectrometry screen of mouse
brain lysates for novel PS1 calcium-dependent interactors. Synaptotagmin 1
(Syt1) was detected in high calcium condition (calcium +) when GST-PS1 L6-7
and GST-PS1 NT recombinant peptides were used for pull-down. Excised band
size and protein matches are indicated. (n= 3; Data from one representative
experiment is shown). (XLSX 20 kb)
Additional file 3: Knock-down and overexpression of Syt1 in PC12 cells.
Representative western blot demonstrates successful stable RNAi-mediated
knock-down of endogenous Syt1 and huSyt1-V5 overexpression in PC12 cell
line. The graph shows quantitative analysis of the rat and rat + human Syt1
levels. Data are presented as mean ± SEM, n= 3 for Syt1 KD+ Syt1-V5 and for
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parental PC12; and n= 4 for other conditions. Statistical significance was
determined using unpaired student t-test; * p < 0.05, ** p < 0.01. (TIF 1863 kb)
Additional file 4: PS1 and APP stability is not affected by Syt1 KD. A,
Parental and Syt1 KD PC12 cells were treated with cycloheximide and
harvested 0, 2, 4, 8, 24, and 48 hours after the treatment. Western blot
presents degradation of PS1 over time. Anti-PS1 C-terminal antibody was
used for detection. The quantitative analysis of PS1 levels reveals no
difference in the half-life of PS1 in Syt1 KD PC12 cells compared to the
parental control. Statistical significance was determined using 2-way
ANOVA with Bonferroni post-test, n = 5. B, Parental and Syt1 KD PC12
cells were treated with cycloheximide and harvested 0, 15, 30, 45, and
90 minutes after the treatment. Western blot presents the level of APP
over time. Anti-APP C-terminal antibody was used for detection. The
quantitative analysis of APP levels revealed no difference in the half-life
of APP in Syt1 KD PC12 cells compared to the parental control. Statistical
significance was determined using 2-way ANOVA with Bonferroni post-test,
n = 3. (TIF 3814 kb)
Additional file 5: Overall transport fidelity is not altered by Syt1 KD. A,
Western blots show distribution of Nct and Pen-2 in 13 subcellular fractions
from parental and Syt1 KD cells. No differences in the subcellular distribution
of Nct and Pen-2 were observed between parental and Syt1 KD cells. The
enrichment of the respective subcellular compartments was determined by
western blotting with anti-calreticulin, anti-GM130, anti-Tgn46, and anti-
Rab11 antibodies. The fractions that correspond to the respective intracellular
compartments are indicated above the western blots. B, Western blots show
distribution of organelle (GM130, Tgn46, calreticulin, and Rab11) and synaptic
vesicle marker, synaptophysin, in 13 subcellular fractions from parental and
Syt1 KD cells. No significant differences in the subcellular distribution of
organelles and synaptophysin (Syp) between parental and Syt1 KD cells
were observed. (TIF 3749 kb)
Additional file 6: Syt1 is not a substrate for γ-secretase. A, B, Western
blots show levels of mature, immature, nascent Syt1, and Syt1 C-terminal
fragments (Syt1 CTF) in mouse primary neurons (A) and PS-/- mouse
embryonic fibroblasts (MEF) transfected with huSyt1-V5 and PS1
(as indicated) (B). Inhibition of the γ-secretase activity with DAPT and
L685,458 did not alter Syt1 processing. GFP (transfection efficiency)
and β actin (loading) are shown as controls. (TIF 1352 kb)
Additional file 7: Supporting data values. The file presents individual
values recorded in the experiments where n < 6. (XLSX 270 kb)
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